Now a paying engagement, CRA’s Life Sciences practice initially began working with LFA on a pro bono project to research the social determinants of health on racial and ethnic minorities who are disproportionately affected by Lupus.
In addition to extensive research, CRA also crafted surveys that were used to collect feedback from LFA’s advisory board, executive team, and patient advocates to gather insights into high-priority solutions for addressing lupus-related health disparities.
